Nkarta (NKTX) Competitor Comparison
We are evaluating the key criteria listed to compare Nkarta (NKTX) against its competitors in the Biotechnology industry.
Market Capitalization
164 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
233 / 337Free Cashflow
300 / 352Quick Ratio
70 / 357Earnings per Share
206 / 359Dividend yield
0 / 6Total Cash
121 / 358Performance 3 years
258 / 368Performance 5 years
321 / 368Performance 10 years
288 / 368Linearity 3 years
188 / 368Linearity 5 years
243 / 368Linearity 10 years
234 / 367Total Rank
339 / 368Dividend Rank
218 / 368Valuation Rank
366 / 368Piotroski Rank
95 / 368Muliplier Rank
164 / 368Market Capitalization - NKTX ranking 164 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.